FRUZAQLA

fruquintinib · Takeda Pharmaceuticals America, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for FRUZAQLA, covering 2023-11-08 to 2026-07-08. Get the full timeline:

Most recent: EMA Authorised: Fruzaqla (fruquintinib) — Takeda Pharmaceuticals International AG Ireland